Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gentiva Health Services Inc (GTIV) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gentiva Health Services Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1096142.
Total stock buying since 2014: $0.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $15,064,087.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 0 | $0 | 0 | $0 | 1,348,984 | $15,064,087 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-12 | 0 | $0 | 0 | $0 | 1,348,984 | $15,064,087 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-12-16 | Slusser Eric (EVP, CFO & Treasurer) | Option Ex | 146,100 | 8.67 | 1,266,687 |
| 2014-12-12 | Windley Rodney D (Executive Chairman) | Option Ex | 125,000 | 10.24 | 1,280,000 |
| 2014-12-04 | Shaner Jeff (SVP, Pres - Operations) | Option Ex | 114,500 | 11.91 | 1,363,351 |
| 2014-12-04 | Causby David A (President & Ch. Oprtng Officer) | Option Ex | 124,066 | 12.58 | 1,560,750 |
| 2014-12-04 | Gieringer David L (SVP, Controller,Ch Acctg Offcr) | Option Ex | 59,300 | 12.55 | 743,977 |
| 2014-12-04 | Weaver Charlotte A (Sr. VP, Chief Clinical Officer) | Option Ex | 73,150 | 8.67 | 634,210 |
| 2014-12-04 | Strange Tony (CEO) | Option Ex | 555,884 | 11.91 | 6,618,910 |
| 2014-12-03 | Camperlengo John N (SVP, General Counsel & Secty) | Option Ex | 150,984 | 10.57 | 1,596,202 |
Insider trading activities including stock purchases, stock sales, and option exercises of GTIV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gentiva Health Services Inc (symbol GTIV, CIK number 1096142) see the Securities and Exchange Commission (SEC) website.